332 related articles for article (PubMed ID: 21829367)
1. IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.
Wilson MS; Cheever AW; White SD; Thompson RW; Wynn TA
PLoS Pathog; 2011 Aug; 7(8):e1002171. PubMed ID: 21829367
[TBL] [Abstract][Full Text] [Related]
2. Immunization with adult
El-Aswad BEW; Harba NM; Moharm IM; Mahmoud SF
J Helminthol; 2019 Jan; 94():e26. PubMed ID: 30702051
[TBL] [Abstract][Full Text] [Related]
3. Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate.
Hanallah S; El-Lakkany N; Mahmoud S; Mousa M; Botros S
APMIS; 2003 Dec; 111(12):1125-32. PubMed ID: 14678022
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
[TBL] [Abstract][Full Text] [Related]
5. Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis.
La Flamme AC; MacDonald AS; Huxtable CR; Carroll M; Pearce EJ
J Immunol; 2003 Jan; 170(1):470-6. PubMed ID: 12496433
[TBL] [Abstract][Full Text] [Related]
6. Defined Intestinal Regions Are Drained by Specific Lymph Nodes That Mount Distinct Th1 and Th2 Responses Against
Mayer JU; Brown SL; MacDonald AS; Milling SW
Front Immunol; 2020; 11():592325. PubMed ID: 33193437
[TBL] [Abstract][Full Text] [Related]
7. Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.
Satti MZ; Cahen P; Skov PS; Joseph S; Jones FM; Fitzsimmons C; Hoffmann KF; Reimert C; Kariuki HC; Kazibwe F; Mwatha JK; Kimani G; Vennervald BJ; Ouma JH; Kabatereine NB; Dunne DW
BMC Immunol; 2004 Apr; 5():6. PubMed ID: 15102330
[TBL] [Abstract][Full Text] [Related]
8. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
Black CL; Muok EM; Mwinzi PN; Carter JM; Karanja DM; Secor WE; Colley DG
J Infect Dis; 2010 Aug; 202(3):399-405. PubMed ID: 20560767
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI
Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706
[TBL] [Abstract][Full Text] [Related]
10. Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host.
Cêtre C; Pierrot C; Cocude C; Lafitte S; Capron A; Capron M; Khalife J
Infect Immun; 1999 Jun; 67(6):2713-9. PubMed ID: 10338473
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.
Pinot de Moira A; Jones FM; Wilson S; Tukahebwa E; Fitzsimmons CM; Mwatha JK; Bethony JM; Kabatereine NB; Dunne DW
Infect Immun; 2013 Jan; 81(1):23-32. PubMed ID: 23071136
[TBL] [Abstract][Full Text] [Related]
12. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.
Tweyongyere R; Mawa PA; Emojong NO; Mpairwe H; Jones FM; Duong T; Dunne DW; Vennervald BJ; Katunguka-Rwakishaya E; Elliott AM
BMC Infect Dis; 2009 Mar; 9():32. PubMed ID: 19296834
[TBL] [Abstract][Full Text] [Related]
13. Praziquantel Treatment of
Nono JK; Mpotje T; Mosala P; Aziz NA; Musaigwa F; Hlaka L; Spangenberg T; Brombacher F
Front Immunol; 2021; 12():748387. PubMed ID: 34956183
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni-specific immune responses and allergy in Uganda.
Nkurunungi G; Kabagenyi J; Nampijja M; Sanya RE; Walusimbi B; Nassuuna J; Webb EL; Elliott AM;
Parasite Immunol; 2018 Jan; 40(1):. PubMed ID: 29171863
[TBL] [Abstract][Full Text] [Related]
15. Strongyloides venezuelensis-infection alters the profile of cytokines and liver inflammation in mice co-infected with Schistosoma mansoni.
de Rezende MC; Moreira JMP; Fernandes LLM; Rodrigues VF; Negrão-Corrêa D
Cytokine; 2020 Mar; 127():154931. PubMed ID: 31783260
[TBL] [Abstract][Full Text] [Related]
16. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to Schistosoma mansoni schistosomula antigens.
Egesa M; Lubyayi L; Jones FM; van Diepen A; Chalmers IW; Tukahebwa EM; Bagaya BS; Hokke CH; Hoffmann KF; Dunne DW; Elliott AM; Yazdanbakhsh M; Wilson S; Cose S
Parasite Immunol; 2018 Dec; 40(12):e12591. PubMed ID: 30239012
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni: protective immunity in IL-4-deficient mice.
King CL; Malhotra I; Jia X
Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774
[TBL] [Abstract][Full Text] [Related]
19. Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens.
Walter K; Fulford AJ; McBeath R; Joseph S; Jones FM; Kariuki HC; Mwatha JK; Kimani G; Kabatereine NB; Vennervald BJ; Ouma JH; Dunne DW
J Immunol; 2006 Oct; 177(8):5490-8. PubMed ID: 17015735
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
